BIOMAT Database Logo BIOMAT Database Logo

[A new combined vaccine against Bordetella parapertussis, diphteria, tetanus and pertussis]. 1965

V Burian, and B Vysoká-Burianová, and M Vrána, and M Kyselová

UI MeSH Term Description Entries
D007223 Infant A child between 1 and 23 months of age. Infants
D010567 Pertussis Vaccine A suspension of killed Bordetella pertussis organisms, used for immunization against pertussis (WHOOPING COUGH). It is generally used in a mixture with diphtheria and tetanus toxoids (DTP). There is an acellular pertussis vaccine prepared from the purified antigenic components of Bordetella pertussis, which causes fewer adverse reactions than whole-cell vaccine and, like the whole-cell vaccine, is generally used in a mixture with diphtheria and tetanus toxoids. (From Dorland, 28th ed) Vaccine, Pertussis
D004166 Diphtheria Antitoxin An antitoxin produced against the toxin of CORYNEBACTERIUM DIPHTHERIAE that is used for the treatment of DIPHTHERIA. Antitoxin, Diphtheria
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D013743 Tetanus Antitoxin An antitoxin used for the treatment of TETANUS. Antitoxin, Tetanus

Related Publications

V Burian, and B Vysoká-Burianová, and M Vrána, and M Kyselová
Diphtheria-tetanus-pertussis vaccine combined with Bordetella parapertussis vaccine.
September 1962, The Journal of hygiene,
V Burian, and B Vysoká-Burianová, and M Vrána, and M Kyselová
Activity of new macrolides against Bordetella pertussis and Bordetella parapertussis.
July 1989, European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology,
V Burian, and B Vysoká-Burianová, and M Vrána, and M Kyselová
Outer membrane vesicles derived from Bordetella parapertussis as an acellular vaccine against Bordetella parapertussis and Bordetella pertussis infection.
October 2013, Vaccine,
V Burian, and B Vysoká-Burianová, and M Vrána, and M Kyselová
Do Pertussis Vaccines Protect Against Bordetella parapertussis?
June 2017, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America,
V Burian, and B Vysoká-Burianová, and M Vrána, and M Kyselová
The efficacy of a whole cell pertussis vaccine and fimbriae against Bordetella pertussis and Bordetella parapertussis infections in respiratory mouse model.
August 1998, Vaccine,
V Burian, and B Vysoká-Burianová, and M Vrána, and M Kyselová
The efficacy of a whole cell pertussis vaccine and fimbriae against Bordetella pertussis and Bordetella parapertussis infections in a respiratory mouse model.
February 1998, Vaccine,
V Burian, and B Vysoká-Burianová, and M Vrána, and M Kyselová
[Repeated diphteria, pertussis, and tetanus immunization].
January 1973, Deutsche medizinische Wochenschrift (1946),
V Burian, and B Vysoká-Burianová, and M Vrána, and M Kyselová
New combined alum hydroxide adsorbed diphtheria-tetanus-pertussis-vaccine with parapertussis component. I. Reactogenicity and serological efficacy.
January 1970, Journal of hygiene, epidemiology, microbiology, and immunology,
V Burian, and B Vysoká-Burianová, and M Vrána, and M Kyselová
Conversion of Bordetella pertussis to Bordetella parapertussis.
August 1978, The Journal of hygiene,
V Burian, and B Vysoká-Burianová, and M Vrána, and M Kyselová
A recombinant iron transport protein from Bordetella pertussis confers protection against Bordetella parapertussis.
October 2017, Microbiology and immunology,
Copied contents to your clipboard!